<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=580450&amp;fmt=gif">

Ghent University Scientists Use VAMS™ to Measure a Novel Biomarker for Alcohol Abuse

Neoteryx Expands European Footprint with Opening of Neoteryx B.V.

Neoteryx LLC Supplies Microsampling Devices for Breakthrough Home Monitoring Initiative, Making Therapeutic Drug Monitoring Fun and Easy for Pediatric Transplant Patients and Their Families

Neoteryx LLC and Cedars-Sinai Partner to Investigate At-Home Blood Sampling Possibilities for Patients with Inflammatory Bowel Disease

New Study Validates Neoteryx's VAMS™ Technology for At-home Blood Collection In Monitoring HbA1c Levels of Diabetic Children

Alcala Labs First to Integrate Neoteryx's VAMS Technology for Substance Abuse Monitoring

Duke University Uses Mitra Devices to Field-Test Diagnostic Tools in Liberia

microsampling goes mainstream

Quest Diagnostics Adds At-Home Collection to Expand Blueprint for Athletes™ Service Using Mitra Microsampling Technology

introducing the HemaTIP™, a microsampling product from Charles River Laboratories

Neoteryx announces an automation solution for Mitra Microsampling technology

Exagen Diagnostics' microsampling method gains wider acceptance

neoteryx adds 20 µL sample collection devices to Mitra microsampling portfolio

mitra microsampler now registered at FDA as a medical device

neoteryx mitra microsampling device wins R&D 100 award

neoteryx and Brechbühler partner to automate the mitra microsampling workflow

neoteryx announces european approval of the mitra microsampling device

neoteryx mitra (RUO) microsampling device simplifies collection, transport, and storage of biological fluids

phenomenex announces spin-off of a microsampling technology company – neoteryx llc